Literature DB >> 35347574

Metastasis prevention: targeting causes and roots.

A A Schegoleva1, A A Khozyainova1, T S Gerashchenko1, L D Zhuikova2, Evgeny V Denisov3.   

Abstract

The spread of tumor cells from the primary focus, metastasis, is the main cause of cancer mortality. Therefore, anticancer therapy should be focused on the prevention of metastatic disease. Key targets can be conditions in the primary tumor that are favorable for the appearance of metastatic cells and the first steps of the metastatic cascade. Here, we discuss different approaches for targeting metastasis causes (hypoxia, metabolism changes, and tumor microenvironment) and roots (angiogenesis, epithelial-mesenchymal transition, migration, and invasion). Also, we emphasize the challenges of the existing approaches for metastasis prevention and suggest opportunities to overcome them. In conclusion, we highlight the importance of clinical evaluation of the agents showing antimetastatic effects in vivo, especially in patients with early-stage cancers, the identification of metastatic seeds, and the development of therapeutics for their eradication.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cancer; Metastasis; Metastatic cascade; Prevention; Therapy

Mesh:

Year:  2022        PMID: 35347574     DOI: 10.1007/s10585-022-10162-x

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   4.510


  142 in total

Review 1.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 2.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

Review 3.  Cancer Screening and Early Detection in the 21st Century.

Authors:  Jennifer T Loud; Jeanne Murphy
Journal:  Semin Oncol Nurs       Date:  2017-03-23       Impact factor: 2.315

4.  Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate.

Authors:  M V Pilepich; K Winter; M J John; J B Mesic; W Sause; P Rubin; C Lawton; M Machtay; D Grignon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-08-01       Impact factor: 7.038

5.  Regional Nodal Irradiation in Early-Stage Breast Cancer.

Authors:  Timothy J Whelan; Ivo A Olivotto; Wendy R Parulekar; Ida Ackerman; Boon H Chua; Abdenour Nabid; Katherine A Vallis; Julia R White; Pierre Rousseau; Andre Fortin; Lori J Pierce; Lee Manchul; Susan Chafe; Maureen C Nolan; Peter Craighead; Julie Bowen; David R McCready; Kathleen I Pritchard; Karen Gelmon; Yvonne Murray; Judy-Anne W Chapman; Bingshu E Chen; Mark N Levine
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

Review 6.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

7.  Are 90% of deaths from cancer caused by metastases?

Authors:  Hanna Dillekås; Michael S Rogers; Oddbjørn Straume
Journal:  Cancer Med       Date:  2019-08-08       Impact factor: 4.452

Review 8.  Engineered models to parse apart the metastatic cascade.

Authors:  Lauren A Hapach; Jenna A Mosier; Wenjun Wang; Cynthia A Reinhart-King
Journal:  NPJ Precis Oncol       Date:  2019-08-21

Review 9.  Cancer metastases: challenges and opportunities.

Authors:  Xiangming Guan
Journal:  Acta Pharm Sin B       Date:  2015-09-08       Impact factor: 11.413

Review 10.  Molecular principles of metastasis: a hallmark of cancer revisited.

Authors:  Jawad Fares; Mohamad Y Fares; Hussein H Khachfe; Hamza A Salhab; Youssef Fares
Journal:  Signal Transduct Target Ther       Date:  2020-03-12
View more
  2 in total

1.  Albumin fusion with human lactoferrin shows enhanced inhibition of cancer cell migration.

Authors:  Hana Nopia; Daisuke Kurimoto; Atsushi Sato
Journal:  Biometals       Date:  2022-09-27       Impact factor: 3.378

Review 2.  The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies.

Authors:  Ruixue Bai; Yunong Li; Lingyan Jian; Yuehui Yang; Lin Zhao; Minjie Wei
Journal:  Mol Cancer       Date:  2022-09-08       Impact factor: 41.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.